IL17A and parasitic infectious disease: Among the promising findings, Pereira-Chiocolla and colleagues demonstrated the protective potential of immunizing mice with T. gondii-derived EVs, resulting in increased specific antibodies, elevated IFN-γ, IL-10, TNF-α, and IL-17 expression, reduced parasitemia, and higher survival rates [45].